Clinical Trial Update: Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of roflumilast cream 0.3% for plaque psoriasis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Roflumilast Cream 0.3% (roflumilast cream)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Plaque Psoriasis | Phase 3 | Status: RECRUITING